Human Polyomavirus JC and BK Persistent Infection

  • Kristina Doerries
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 577)


Primary contact with the human polyomaviruses (HPV) is followed by lifelong persistence of viral DNA in its host. The most prominent organs affected are the kidney, the Central Nervous System (CNS) and the hematopoietic system. Under impairment of immune competence limited activation of virus infection can be followed by prolonged virus multiplication, severe destruction of tissue and disease. The mechanisms responsible for activation episodes of the asymptomatic persistent infection are not understood and questions on cellular localization, routes of dissemination of HPV infection and its activation are controversially discussed. The type of interaction of HPVs with target organs and patients groups is highly differentiated. Organ-specific activation above basic level argues for strong dependence on the respective immune states of risk group patients. However, since immune impairment generally plays an important role in the activation of polyomavirus infection, amplification of virus deoxyribonudeic acid (DNA) and activation of virus replication is also a normal event that is probably subject to immunomodulation in the healthy individual. It also becomes clear that BKV and JCV infection is differentially regulated by mechanisms depending on the balance of immune control as well as on organ-specific signalling.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hirsch HH, Steiger J. Polyomavirus BK. Important review on BKV virology and pathogenesis. Lancet Infect Dis 2003; 3:611–623.PubMedCrossRefGoogle Scholar
  2. 2.
    Walker DL, Padgett BL. The classical summary on PML. Progressive multifocal leukoencephalopathy. New York: Plenum Press, 1983; 18:161–193.Google Scholar
  3. 3.
    Doerries K, Sbiera S, Drews K et al. A study on JCV affected peripheral blood cell subopopulations emphasizing granulocytes as major affected cell type. Association of human polyomavirus JC with peripheral blood of immunoimpaired and healthy individuals. J Neurovirol 2003; 9(Suppl 1):81–87.CrossRefGoogle Scholar
  4. 4.
    Arthur RR, Shah KV. Occurrence and significance of papovaviruses BK and JC in the urine. A summary of early studies of JCV and BKV viruria that remains a valuable source for the understanding of persistent huPyV infections. Prog Med Virol 1989; 36:42–61.PubMedGoogle Scholar
  5. 5.
    Doerries K. Latent and persistent human polyomavirus infection. Extensive review on persistent polyomavirus infection. In: Khalili K, Stoner GL, eds. Human Polyomaviruses. Molecular and clinical perspectives. New York: Wiley-Liss Inc. 2001:197–237.Google Scholar
  6. 6.
    Koralnik IJ, Boden D, Mai VX et al. JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy. Important paper on the presence of JCV in different target compartments. Neurology 1999a; 52(2):253–260.PubMedGoogle Scholar
  7. 7.
    Du Pasquier RA, Corey S, Margolin DH et al. Productive infection of cerebellar granule cell neurons by JC virus in an HIV+ individual. The first report on the involvement of neurons in JCV infection. Neurology 2003; 61:775–782.PubMedGoogle Scholar
  8. 8.
    von Einsiedel RW, Samorei IW, Pawlita M et al. New JC virus infection patterns by in situ polymerase chain reaction in brains of acquired immunodeficiency syndrome patients with progressive multifocal leukoencephalopathy. Characterization of affected cell types and topography of PML lesions by modern molecular methods. J Neurovirol 2004; 10:1–11.CrossRefGoogle Scholar
  9. 9.
    Doerries K. Human polyomaviruses in target cells of hematopoietic origin and mechanisms of activation in the course of infection. The review concentrates on interaction of huPyV with cells of hematopoietic origin. Current topics in Virology 1999b; 1:84–93.Google Scholar
  10. 10.
    Jensen PN, Major EO. Viral variant nudeotide sequences help expose leukocytic positioning in the JC virus pathway to the CNS. Concentrates on the possible role of JCV variants for viral dissemination. J Leukoc Biol 1999; 65:428–438.PubMedGoogle Scholar
  11. 11.
    Koralnik IJ, Schmitz JE, Lifton MA et al. Detection of JC virus DNA in peripheral blood cell subpopulations of HIV-1-infected individuals. Characterization of PBC subpopulations involved in JCV infection. J Neurovirol 1999b; 5:430–435.PubMedCrossRefGoogle Scholar
  12. 12.
    Wei G, Liu CK, Atwood WJ. JC virus binds to primary human glial cells, tonsillar stromal cells, and B-lymphocytes, but not to T lymphocytes. Addresses the role of transcription factors and cell receptors for JCV infection. J Neurovirology 2000; 6:127–136.CrossRefGoogle Scholar
  13. 13.
    Monaco MC, Sabath BF, Durham LC et al. JC virus multiplication in human hematopoietic progenitor cells requires the NF-1 class D transcription factor. Dependence of JCV replication on transcription factor family NF expression. J Virol 2001; 75:9687–9695.PubMedCrossRefGoogle Scholar

Copyright information

© and Springer Science+Business Media 2006

Authors and Affiliations

  • Kristina Doerries
    • 1
  1. 1.Institute for Virology and ImmunobiologyUniversity of WuerzburgWuerzburgGermany

Personalised recommendations